Академический Документы
Профессиональный Документы
Культура Документы
Materials Chemistry B
View Article Online
PAPER View Journal | View Issue
Mushrooms are known as a delicacy due to their delicious taste and rich nutrition, and their b-glucans
have antitumor activity. Here, a triple helical b-glucan (THG) isolated from Lentinus edodes was
successfully fractionated into nine fractions with different weight-average molecular weights (Mw)
through ultrasonic irradiation. The Mw, radius of gyration (hRgiz), hydrodynamic radius (hRhiz), structure-sensitive
parameters (r), contour length (L), persistence length (q) and molar mass per contour length (ML) were
characterized by static light scattering (SLS), dynamic light scattering (DLS), and atomic force microscopy (AFM).
The results indicated that THG displayed an extended chain conformation with r values of 2.1 0.1 for the
nine fractions, as well as ML and q values of 2160 nm1 and 110 nm in water, which were consistent with the
data for triple helical polysaccharides. In combination with the apparent length (Lap) values visualized with AFM
and Mw, the molar mass per apparent contour length (MLap) was calculated to be 2242 nm1, which was similar
to that obtained from SLS according to the wormlike cylinder model. Thus, we established a novel method
using AFM for characterizing the chain stiffness of polysaccharides. The results from an animal assay
demonstrated that THG significantly inhibited H22 tumor growth without damage to organisms, and the THG
fractions with relatively low molecular weight and/or higher stiffness showed stronger antitumor activity,
Received 15th May 2017, revealing the significant molecular weight- and chain conformation-dependences of antitumor activity.
Accepted 21st June 2017 Moreover, a schematic model to describe the interaction between THG and receptors on the immune cell
DOI: 10.1039/c7tb01324h membrane was proposed to illustrate these results. This work provides important information for characterizing
the chain conformation of polysaccharides and understanding the relationship between structure and antitumor
rsc.li/materials-b activity, which is relevant for the treatment of hepatocellular carcinoma in clinic.
This journal is © The Royal Society of Chemistry 2017 J. Mater. Chem. B, 2017, 5, 5623--5631 | 5623
View Article Online
stimulatory.27 However, the influence of the chain conformation according to the method established by our laboratory.36 The
and molecular weight on the biological activities of the b-glucans extract is denoted THG herein (Fig. S1, ESI†). The chemical
is not well established yet, due to the great difficulty of both the structure of THG has been identified by NMR and GC-MS
preparation of glucan samples and the characterization of their analysis to be a b-1,3-D-glucan with two b-1,6-D-glucopyranoside
conformations. branches for every five b-1,3-glucopyranoside linear linkages.36 It
Mushrooms have been considered as a delicious, richly has been reported that ultrasonic degradation is a viable physical
nutritious food in Asia for centuries. The b-glucan isolated method for schizophyllan (SPG) and does not cause changes in
from an edible mushroom, Lentinus edodes, was first found to higher-order structure.39 Briefly, the THG sample was dissolved
in water at a concentration of 2.0 mg mL1 and degraded by
Published on 23 June 2017. Downloaded by Universidade Federal do Parana on 16/03/2018 13:08:44.
5624 | J. Mater. Chem. B, 2017, 5, 5623--5631 This journal is © The Royal Society of Chemistry 2017
View Article Online
2.4 Atomic force microscopy Germany). For immunohistochemical analysis, slides were
THG samples were dissolved in ultrapure water at concentrations incubated with primary antibodies including anti-Bcl-2, anti-
of 1 mg mL1, and then diluted to the desired concentrations. A Bax, and anti-caspase-3 (Servicebio, each at 1 : 100 dilution),
drop of 5 mL diluted THG solution was placed on freshly cleaved and observed under a light microscope.
mica and allowed to dry in air at room temperature. Topographic
2.7 Apoptosis analysis and cell viability assay in vitro
images of THG samples in water were recorded using a commercial
atomic force microscope (Cypher ES, Asylum Research, Oxford, USA) Apoptosis analysis was measured by using the Annexin V-FITC/
in AC mode at 35 1C. Silicon probes with a spring constant of PI double staining apoptosis detection kit (KeyGEN BioTECH).
Published on 23 June 2017. Downloaded by Universidade Federal do Parana on 16/03/2018 13:08:44.
2 N m1 and resonance frequency of 70 kHz (ASYELEC-01, Asylum H22 cells were cultured in 6-well plates and treated with 0, 50,
Research) were employed. The average radius of the tip was 28 nm. 100 or 200 mg mL1 THG for 72 h. Cells were collected and
All data from the images were analyzed using the AFM accessory washed twice with PBS, then incubated with Annexin V-FITC/PI
software, and the images presented were flattened only when for 15 min in the dark at room temperature following the
necessary. manufacturer’s protocol. Samples were then analyzed within
1 h by flow cytometry (BD Biosciences). The cell viability of H22
2.5 Antitumor activity in vivo cells was detected using a Live/Dead Cell Double Staining Kit
(Sigma, USA). H22 cells were cultured in 6-well plates and treated
The mouse hepatoma carcinoma cell line (H22) was purchased
with 0, 50, 100 or 200 mg mL1 THG. After 72 h incubation,
from the China Center for Type Culture Collection (CCTCC,
collected cells were washed twice with PBS and stained with
Wuhan, China). The cell was cultured in the Roswell Park
Calcein-AM/PI at 37 1C for 15 min following the manufacturer’s
Memorial Institute 1640 medium (RPMI 1640, HyClone) with
protocol. The cells were visualized with a fluorescence micro-
penicillin (100 U mL1), streptomycin (100 mg mL1) and 10%
scope (Leica DMi8, Germany).
heat-inactivated (56 1C, 30 min) fetal bovine serum (FBS, Gibco)
Cell viability was determined by using a standard 3-(4,5-
at 37 1C under a humidified atmosphere of 95% air and 5%
dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT)
CO2. Six-week-old BALB/c mice (male, weighing 20 1 g) were
assay. Different kinds of cells (H22, HepG2, HeLa, MCF-7, MNK-
purchased from the Center for Animal Experiment ABSL-III
45, SH-sy5y, L02 and RAW264.7, purchased from CCTCC) were
Laboratory of Wuhan University (Hubei, China). Animal study
seeded in 96-well plates at a density of 5 103 cells per well in final
protocols were approved by the Institutional Animal Care and
volumes of 200 mL and incubated for 12 h. The cells were then
Use Committee (IACUC) of Wuhan University. The mouse
incubated with THG at final concentrations of 0, 50, 100, 150 or
subcutaneous (s.c.) tumor transplantation models were used
200 mg mL1. After 72 h incubation, 20 mL of MTT (5 mg mL1,
to evaluate the antitumor activity of THG samples. Briefly,
Sigma) solution was added to each well and incubated for 4 h at
BALB/c mice were injected subcutaneously with H22 tumor
37 1C with 5% CO2. The supernatant was then removed care-
cells (1 106 per mouse) in 0.1 mL 0.9% NaCl into the right
fully, and the cells were treated with 150 mL of dimethyl
armpit. After inoculation for 24 h, mice were randomly
sulfoxide (DMSO, Sinopharm, China), followed by gentle shaking.
assigned to different treatment groups and treated daily with
The plates were analyzed at a wavelength of 492 nm on a microplate
an intraperitoneal (i.p.) injection of saline (negative control),
reader (BMG LABTECH, FLUOstar OPTIMA, Germany). The data are
5-Fu (20 mg kg1, positive control), THG (0.5 mg kg1, 1 mg kg1,
presented as cell viability (%) = [(Experimental group Blank
5 mg kg1, 10 mg kg1) or THG fractions (from THG1 to THG9,
group)/(Negative control group Blank group)] 100%.
5 mg kg1) for 20 days. Then all mice were weighed and
sacrificed. All the tumors and spleens were removed and
2.8 Statistical analysis
weighed. According to the mean weight of the tumors, the tumor
inhibition rates were calculated as follows: tumor inhibition rate All data are presented as the mean S.E. from at least three
(%) = [(Average tumor weight of the control group Average independent experiments unless specified otherwise. The student’s
tumor weight of the test group)/(Average tumor weight of the t test was performed, and the differences were considered
control group)] 100%. The spleen index was expressed as the statistically significant at p o 0.05. Survival curves were created
spleen weight relative to the body weight. For a survival assay, tumor- using the Kaplan–Meier method, and statistical analyses of
bearing mice were treated as above and observed over 60 days. survival curves used a log-rank test.
This journal is © The Royal Society of Chemistry 2017 J. Mater. Chem. B, 2017, 5, 5623--5631 | 5625
View Article Online
For THG, the values of ML, q and contour length per main-chain
residue (h) can be calculated using the molar mass of the THG
repeating unit (M0 = 1134) according to the following
equations:34,35
h = (M0/5)/(ML/3) (5)
5626 | J. Mater. Chem. B, 2017, 5, 5623--5631 This journal is © The Royal Society of Chemistry 2017
View Article Online
Fig. 2 AFM images of THG1 (a), THG3 (b), THG5 (c), THG7 (d), THG8 (e),
and THG9 (f) in water at concentrations of 2 mg mL1. Apparent contour
length distributions f (Lap) of THG1 (g). Dependence of Mw on Lap for THG Fig. 3 THG showed significant dosage-dependent antitumor activity in
fractions (h). H22 bearing mice. H22 tumor-bearing mice were intraperitoneally
injected with or without THG for 20 days, and then weighed and sacrificed.
The weights of extracted tumors (a). The photos of extracted tumors (b).
conformation parameters were in agreement with those of The tumor inhibition rate of THG (c). The body weights of tumor-bearing
ML = 2150 150 nm1, q = 200 30 nm and d = 2.6 0.4 nm mice (d). The spleen index of tumor-bearing mice (e). Survival curves of
tumor-bearing mice after 60 days treatment (f). The bars represent the
for triple helical SPG in water.45,46 Thus, a simple method using
S.E., *p o 0.05. Survival curves were created using the Kaplan–Meier
AFM to characterize morphology and contour length of the method, and statistical analyses of survival curves used a log-rank test.
extended chain was established. Furthermore, with a decrease of
molecular weight, the THG chains changed from long extended
chains to short rods as shown in the AFM images. Thus, the chain
THG treatment. Interestingly, THG exhibited weak antitumor
conformation and stiffness of polysaccharides could be visualized
activity at either high (10 mg kg1) or low (0.5 mg kg1) dosage,
via AFM.
showing a different dosage-dependence to that seen with
chemical drugs. The mice survival rates also showed similar
3.3 Influences of chain conformation and molecular weight dosage-dependence after 60 days treatment (Fig. 3f), namely,
on antitumor activity of THG the dosages of 5 and 1 mg kg1 led to the highest survival rate
Hepatocellular carcinoma (HCC), with increasing worldwide of 80%, while the dosages of 10 and 0.5 mg kg1 only slightly
incidence, is one of the most common and lethal malignancies prolonged the life of mice compared with the negative control.
in the world.47,48 Dosage-dependence is a very important factor In general, the therapeutic effect of chemical drugs increases
of any drug in clinical application. Here, murine hepatocellular with increasing dosage. The different dosage-dependence of
carcinoma H22 cell suspensions were injected subcutaneously THG for antitumor activity suggested that THG acted in a
into the right flank of groups of mice to develop tumor-bearing different way to 5-Fu. In our previous work, we have demonstrated
mice, which were treated daily with i.p. injections of THG at that the b-glucan from Lentinus edodes inhibits S-180 tumor growth
dosages of 0.5 mg kg1, 1 mg kg1, 5 mg kg1, or 10 mg kg1, through activating immune cells,38 and it has been reported that
according to group. As shown in Fig. 3a and b, the mean tumor the binding of polysaccharides to receptors on the surface of
weight was effectively inhibited by THG with values ranging immune cells initiates the immune responses.24,25 As is widely
from 1.11 g (the saline control group) to 0.50 g (5 and 1 mg kg1 known, polysaccharides easily self-aggregate due to the strong
THG groups; inhibition of 55% after 20 days treatment, Fig. 3c). hydrogen bonding between hydroxyls in polymer chains.49,50 It is
In contrast to the saline control group, the tumor growth of the thus speculated that aggregation may reduce the binding of
positive control group (5-Fu, 20 mg kg1) was significantly polysaccharide chains to receptors, leading to weak or even no
depressed. However, the body weight and spleen index were activation of immune responses. DLS was then performed to study
seriously decreased with 5-Fu (Fig. 3d and e), and no such side whether or not aggregation of THG occurred within the used
effects occurred in THG groups, indicating the good safety of dosage range. The apparent hydrodynamic radius distribution
This journal is © The Royal Society of Chemistry 2017 J. Mater. Chem. B, 2017, 5, 5623--5631 | 5627
View Article Online
f (Rh) of THG samples with different concentrations (Fig. S5, continued increase in concentration, the chains of THG over-
ESI†) displayed only one symmetric peak with the same lapped into intricate networks (Fig. 4e), similar to those reported
peak position in dilute solutions at concentrations lower than for triple helical SPG and stiff polysaccharide AF1.56,57 The
1 mg mL1, demonstrating that only isolated THG chains average height of overlapped chains was 1.89 0.26 nm
(individuals) existed in these solutions. Two peaks occurred at (Fig. 4f), confirming that the stiff chain conformation of THG
the concentration of 1 mg mL1, corresponding to individual easily self-aggregated with increased concentration. It is worth
chains at the lower position and THG aggregates at the higher noting that the superimposition of different strands makes the
position. The aggregation of THG was further evidenced by AFM evaluation of heights difficult when a polymer network is present.
THG strongly self-aggregated at a concentration of 1 mg mL1 or
Published on 23 June 2017. Downloaded by Universidade Federal do Parana on 16/03/2018 13:08:44.
5628 | J. Mater. Chem. B, 2017, 5, 5623--5631 This journal is © The Royal Society of Chemistry 2017
View Article Online
or spleen index for THF treated groups, compared with the staining and TUNEL staining assays. In the HE staining assay, a
saline control (Fig. 5c and Fig. S6, ESI†). Furthermore, the distinct irregular arrangement of karyomorphism and nuclear
survival rates of the mice treated with THG fractions were rupture were observed in THG-treated and 5-Fu-treated mice
significantly higher than those of the saline control and 5-Fu but not in the saline control (Fig. 6a). Compared with the
groups (Fig. 5d), suggesting the good therapeutic effect and control group, cell apoptosis happened in THG-treated tumor
safety of the THG fractions. Interestingly, the THG fractions tissues as well as in 5-Fu-treated mice (Fig. 6b). Moreover, THG
with lower molecular weights (3.01 105–1.01 106) exhibited down-regulated the level of the anti-apoptotic protein Bcl-2,
larger inhibitory effects than those with higher molecular and up-regulated the level of the pro-apoptotic proteins Bax and
weights (1.16 106–1.76 106) against H22 tumor growth,
Published on 23 June 2017. Downloaded by Universidade Federal do Parana on 16/03/2018 13:08:44.
This journal is © The Royal Society of Chemistry 2017 J. Mater. Chem. B, 2017, 5, 5623--5631 | 5629
View Article Online
body weight and spleen index from the THG-treated mice compared
with the saline control. This showed the good therapeutic effect and
safety of THG. Moreover, the antitumor activity of THG was affected
seriously by its Mw and chain conformation, revealing the significant
molecular weight- and chain conformation-dependences of
antitumor activity. In our findings, the higher antitumor activity
was a result of relatively stronger interactions of THG fractions
having more isolated extended triple helical chains with receptors
Published on 23 June 2017. Downloaded by Universidade Federal do Parana on 16/03/2018 13:08:44.
5630 | J. Mater. Chem. B, 2017, 5, 5623--5631 This journal is © The Royal Society of Chemistry 2017
View Article Online
16 H. Lu, Y. Yang, E. Gad, C. A. Wenner, A. Chang, E. R. Larson, 37 U. Surenjav, L. Zhang, X. Xu, X. Zhang and F. Zeng, Carbohydr.
Y. Dang, M. Martzen, L. J. Standish and M. L. Disis, Clin. Polym., 2006, 63, 97–104.
Cancer Res., 2011, 17, 67–76. 38 H. Xu, S. Zou, X. Xu and L. Zhang, Sci. Rep., 2016, 6, 28802.
17 F. Hong, J. Yan, J. T. Baran, D. J. Allendorf, R. D. Hansen, 39 K. Zhong, Q. Zhang, L. Tong, L. Liu, X. Zhou and S. Zhou,
G. R. Ostroff, P. X. Xing, N.-K. V. Cheung and G. D. Ross, Ultrason. Sonochem., 2015, 23, 75–80.
J. Immunol., 2004, 173, 797–806. 40 B. H. Zimm, J. Chem. Phys., 1948, 16, 1093–1099.
18 I. C. Diller, Z. T. Mankowski and M. E. Fisher, Cancer Res., 41 Y. Zhang, X. Xu, J. Xu and L. Zhang, Polymer, 2007, 48,
1963, 23, 201–208. 6681–6690.
Published on 23 June 2017. Downloaded by Universidade Federal do Parana on 16/03/2018 13:08:44.
19 R. Zhang and K. J. Edgar, Biomacromolecules, 2014, 15, 42 M. Sletmoen, E. Geissler and B. T. Stokke, Biomacro-
1079–1096. molecules, 2006, 7, 858–865.
20 Y. Masuda, H. Inoue, H. Ohta, A. Miyake, M. Konishi and 43 L. Yu, X. Xu, J. Zhou, G. Lv and J. Chen, Food Hydrocolloids,
H. Nanba, Int. J. Cancer, 2013, 133, 108–119. 2017, 65, 165–174.
21 Y. Masuda, D. Nawa, Y. Nakayama, M. Konishi and 44 T. L. Bluhm and A. Sarko, Can. J. Chem., 1977, 55, 293–299.
H. Nanba, J. Leukocyte Biol., 2015, 98, 1015–1025. 45 T. Yanaki, T. Norisuye and H. Fujita, Macromolecules, 1980,
22 S. LeibundGut-Landmann, O. Grosz, M. J. Robinson, 13, 1462–1466.
F. Osorio, E. C. Slack, S. V. Tsoni, E. Schweighoffer, 46 Y. Kashiwagi, T. Norisuye and H. Fujita, Macromolecules,
V. Tybulewicz, G. D. Brown, J. Ruland and C. Reis e Sousa, 1981, 14, 1220–1225.
Nat. Immunol., 2007, 8, 630–638. 47 A. Arzumanyan, H. M. G. P. V. Reis and M. A. Feitelson, Nat.
23 S. LeibundGut-Landmann, F. Osorio, G. D. Brown and Rev. Cancer, 2013, 13, 123–135.
C. Reis e Sousa, Blood, 2008, 112, 4971–4980. 48 R. L. Siegel, K. D. Miller and A. Jemal, Ca-Cancer J. Clin.,
24 G. Chan, W. K. Chan and D. Sze, J. Hematol. Oncol., 2009, 2016, 66, 7–30.
2, 25. 49 S. Xu, Y. Lin, J. Huang, Z. Li, X. Xu and L. Zhang, J. Mater.
25 H. Huang, G. R. Ostroff, C. K. Lee, S. Agarwal, S. Ram, Chem. A, 2013, 1, 4198–4206.
P. A. Rice, C. A. Specht and S. M. Levitz, J. Immunol., 2012, 50 J.-Y. Yin, S.-P. Nie, Q.-B. Guo, Q. Wang, S. W. Cui and
189, 312–317. M.-Y. Xie, Carbohydr. Polym., 2015, 124, 331–336.
26 A. Mueller, J. Raptis, P. J. Rice, J. H. Kalbfleisch, R. D. Stout, 51 A. K. Vuppu, A. A. Garcia and C. Vernia, Biopolymers, 1997,
H. E. Ensley, W. Browder and D. L. Williams, Glycobiology, 42, 89–100.
2000, 10, 339–346. 52 T. M. McIntire and D. A. Brant, J. Am. Chem. Soc., 1998, 120,
27 J. A. Cleary, G. E. Kelly and A. J. Husband, Immunol. Cell 6909–6919.
Biol., 1999, 77, 395–403. 53 T. M. McIntire and D. A. Brant, Biopolymers, 1997, 42, 133–146.
28 K. Oba, M. Kobayashi, T. Matsui, Y. Kodera and J. Junichi, 54 T. M. McIntire, R. M. Penner and D. A. Brant, Macromolecules,
Anticancer Res., 2009, 29, 2739–2745. 1995, 28, 6375–6377.
29 S. Yoshino, T. Tabata, S. Hazama, N. Iizuka, K. Yamamoto, 55 L. Schefer, I. Usov and R. Mezzenga, Biomacromolecules,
M. Hirayama, A. Tangoku and M. Oka, Anticancer Res., 2000, 2015, 16, 985–991.
20, 4707–4711. 56 C. Li, M. Numata, A.-H. Bae, K. Sakurai and S. Shinkai,
30 Y. Y. Maeda and G. Chihara, Nature, 1971, 229, 634. J. Am. Chem. Soc., 2005, 127, 4548–4549.
31 S. Yoshino, S. Watanabe, M. Imano, T. Suga, S. Nakazawa, 57 Y. Meng, S. Zou, M. Jiang, X. Xu, B. Z. Tang and L. Zhang,
S. Hazama and M. Oka, Hepato-Gastroenterology, 2010, 57, J. Mater. Chem. B, 2017, 5, 2616–2624.
172–177. 58 Z. Ping, H. Xu, T. Liu, J. Huang, Y. Meng, X. Xu, W. Li and
32 D. Higashi, K. Seki, Y. Ishibashi, Y. Egawa, M. Koga, L. Zhang, J. Mater. Chem. B, 2016, 4, 4565–4573.
T. Sasaki, K. Hirano, K. Mikami, K. Futami, T. Maekawa 59 C. Qi, Y. Cai, L. Gunn, C. Ding, B. Li, G. Kloecker, K. Qian,
and M. Sudo, Anticancer Res., 2012, 32, 2365–2368. J. Vasilakos, S. Saijo, Y. Iwakura, J. R. Yannelli and J. Yan,
33 H. Kataoka, T. Shimura, T. Mizoshita, E. Kubota, Y. Mori, Blood, 2011, 117, 6825–6836.
T. Mizushima, T. Wada, N. Ogasawara, S. Tanida, M. Sasaki, 60 J. Tian, J. Ma, K. Ma, H. Guo, S. E. Baidoo, Y. Zhang, J. Yan,
S. Togawa, H. Sano, Y. Hirata, M. Ikai, H. Mochizuki, K. Seno, L. Lu, H. Xu and S. Wang, Eur. J. Immunol., 2013, 43,
S. Itoh, T. Kawai and T. Joh, Hepato-Gastroenterology, 2009, 56, 1220–1230.
547–550. 61 Y. Ning, D. Xu, X. Zhang, Y. Bai, J. Ding, T. Feng, S. Wang,
34 L. N. Zhang, X. F. Zhang, Q. Zhou, P. Y. Zhang, M. Zhang N. Xu, K. Qian, Y. Wang and C. Qi, Int. J. Cancer, 2016, 138,
and X. L. Li, Polym. J., 2001, 33, 317–321. 2713–2723.
35 L. Zhang, X. Li, X. Xu and F. Zeng, Carbohydr. Res., 2005, 62 X. Xu, C. Pan, L. Zhang and H. Ashida, J. Biol. Chem., 2011,
340, 1515–1521. 286, 31194–31198.
36 S. Li, Y. Huang, S. Wang, X. Xu and L. Zhang, J. Phys. Chem. B, 63 X. Xu, M. Yasuda, S. Nakamura-Tsuruta, M. Mizuno and
2014, 118, 668–675. H. Ashida, J. Biol. Chem., 2012, 287, 871–878.
This journal is © The Royal Society of Chemistry 2017 J. Mater. Chem. B, 2017, 5, 5623--5631 | 5631